Skip to main content

Closed

LENZ: LENZ Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-563.8%

ROIC-47.9%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio10.40×

LENZ Therapeutics, Inc.

LENZNASDAQ Global Select·USD·Closed

LENZ Therapeutics, Inc.

LENZNASDAQ·USD·Closed

$5.30

−7.99%

$5.30

−$0.46 (7.99%)

52W Range

1thpctl

Volume

0.95×avg

Mkt Cap

166.18MUSD

P/E

-1.5TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.95×avg

Market Cap

166.18MUSD

P/E Ratio

-1.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings